Perfusion Companies

Latest Perfusion Companies Update

Nov 2023: Raising the standard for patient comfort and therapy compliance, Terumo India, the Indian division of the world-renowned medical technology company Terumo Corporation, announced the launch of Insulin Syringe, a sterile delivery device for patients needing frequent insulin injections. The syringe has a premium silicone surface and a 3-bevel ultra-sharp needle, making it gentler and more comfortable for patients. Its special plunger retention mechanism prevents spills and dose waste. The device has different needle sizes and is marked with U 40 and U 100 scales. The Insulin Syringe is a product of Terumo Corporation, which has a 102-year history of reliability and concern. The organization collaborates closely with its clients and academic partners to run several highly regarded training and development initiatives.

Apr 2023: For its Icast covered stent system, which has been used by physicians for 20 years under the trade name Advanta V12, the US FDA granted Getinge AB premarket approval (PMA). A form of peripheral artery illness called iliac arterial occlusive disease, in which atherosclerosis narrows and obstructs peripheral arteries, is the condition for which Icast is intended as a treatment.List of Perfusion Key companies in the market

• Getinge AB (Sweden)


• Medtronic (Ireland)


• LivaNova PLC (U.K.)


• Terumo Medical Corporation (Japan)


• XENIOS AG (Germany)


• Lifeline Scientific, Inc. (U.S.)


• XVIVO Perfusion (Sweden)


• Repligen Corporation (U.S.)


• Spectrum Laboratories, Inc. (U.S.)


• Merck KGaA (Germany)


• Harvard Bioscience, Inc. (U.S.)


• Ala Science (U.S.)